Faute de régulation, la communauté est aux prises avec une perte des valeurs et le crime organisé.

Un microbiologiste du ministère n'avait rien trouvé d'anormal un an avant les révélations d'Enquête.

Karine Boivin Roy se dit réceptive aux inquiétudes quant au guichet unique pour le logement abordable.

Paul St-Pierre Plamondon sera le premier chef de parti à discuter de questions internationales avec l’organisme.

Un homme dans la vingtaine a perdu la vie après avoir été heurté tôt vendredi matin sur le boulevard Taschereau, dans le quartier LeMoyne à Longueuil, par un conducteur qui a pris la fuite.

Un homme de 59 ans repose dans un état critique après que son automobile ait percuté une terrasse sur la rue Sherbrooke Ouest, dans l’arrondissement montréalais de Côte-des-Neiges–Notre-Dame-de-Grâce, dans la nuit de jeudi à vendredi.

Additional changes in company executive leadership also announced TORONTO, May 15, 2026 (GLOBE NEWSWIRE) — POET Technologies Inc. (NASDAQ: POET) (the “Corporation”), the designer and developer of Photonic Integrated Circuits (PICs), light sources and optical modules for the AI and data center markets, today announced it has entered into a definitive agreement to issue and sell 19,047,620 common shares (the “Common Shares”) and a warrant exercisable for 19,047,620 Common Shares (the “Warrant” and together with the Common Shares, the “Offered Securities”) to a single institutional investor in a non-brokered registered direct offering. The combined price of one Common Share and the accompanying Warrant in respect of one Common Share will be US$21.00, raising aggregate gross proceeds of US$400,000,020. The Warrant will be exercisable at an exercise price of US$26.15 per Common Share for a period of three years from the date of issuance. The closing of the financing is expected to take place on or about Monday, May 18, 2026, subject to the satisfaction of customary closing conditions.   The combined price for the Offered Securities represents a premium over the closing price of the Corporation’s common stock as quoted on the NASDAQ Capital Market of US$20.57 on Thursday, May 14, 2026. The Corporation intends to use the net proceeds from this investment for the expansion of its manufacturing infrastructure, support for corporate development activities, including targeted acquisitions, scaling up of R&D, acceleration of the light source business, expanding operations, and general working capital. This offering is being made pursuant to an automatic shelf registration statement on Form F-3 that was filed with the U.S. Securities and Exchange Commission (the “SEC”) and became automatically effective on January 22, 2026. A prospectus supplement relating to the offering will be filed with the SEC and will be available on the SEC’s website located at www.sec.gov. Electronic copies of the prospectus supplement may be obtained, when available, by contacting the Corporation by phone at (416) 368-9411 or by email at legal.poet.tech. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Executive Leadership Changes As noted in the Company’s press release dated May 12, 2026, POET previously announced the appointment of Sandeep Kumar as Chief Operating Officer. In addition, Thomas Mika, the Company’s longstanding Chief Financial Officer, has informed the Company’s board of directors (the “Board”) of his desire to retire sometime this year from this role, after ten years of service to the Company. The Board has acknowledged Mr. Mika’s decision and is commencing a search for a suitable successor. About POET Technologies Inc. POET is a design and development company offering high-speed optical engines, light source products and custom optical modules to the artificial intelligence systems market and to hyperscale data centers. POET’s photonic integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using advanced wafer-level semiconductor manufacturing techniques. POET’s Optical Interposer-based products are lower cost, consume less power than comparable products, are smaller in size and are readily scalable to high production volumes. In addition to providing high-speed (800G, 1.6T and above) optical engines and optical modules for AI clusters and hyperscale data centers, POET has designed and produced novel light source products for chip-to-chip data communication within and between AI servers, the next frontier for solving bandwidth and latency problems in AI systems. POET’s Optical Interposer platform also solves device integration challenges across a broad range of communication, computing and sensing applications. POET is headquartered in Toronto, Canada, with operations in Singapore, Penang, Malaysia and Shenzhen, China. More information about POET is available on our website at www.poet-technologies.com   Media Relations Contact:Adrian BrijbassiAdrian.Brijbassi@poet.tech Company Contact:Thomas R. Mika, EVP & CFOtm@poet.tech Cautionary Note Regarding Forward-Looking Information This news release contains “forward-looking information” (within the meaning of applicable Canadian securities laws) and “forward-looking statements” (within the meaning of the U.S. Private Securities Litigation Reform Act of 1995). Such statements or information are identified with words such as “anticipate”, “believe”, “expect”, “plan”, “intend”, “potential”, “estimate”, “propose”, “project”, “outlook”, “foresee” or similar words suggesting future outcomes or statements regarding any potential outcome. Such statements include, without limitation, the Company’s expectations with to the closing of the financing and the use of proceeds thereof and expectations as to a change in the Company’s executive team. capitalized upon the closing of the offering and the Company being able to advance its business objectives. Such forward-looking information or statements are based on a number of risks, uncertainties and assumptions which may cause actual results or other expectations to differ materially from those anticipated and which may prove to be incorrect. Actual results could differ materially due to a number of factors, including, without limitation, the risk that the conditions to the closing of the financing will not be satisfied, potential changes in the Company’s capital needs and challenges associated with finding a suitable new chief financial officer. . For further information concerning these and other risks and uncertainties, refer to the Company’s filings on SEDAR+ at www.sedarplus.ca and with the U.S. Securities and Exchange Commission at www.sec.gov. Prospective investors in the Company’s securities should not place undue reliance on forward-looking statements because the Company can provide no assurance that such expectations will prove to be correct. Forward-looking information and statements contained in this news release are as of the date of this news release and the Company assumes no obligation to update or revise the forward-looking information and statements except as required by applicable securities laws.120 Eglinton Avenue, East, Suite 1107, Toronto, ON, M4P 1E2- Tel: 416-368-9411 – Fax: 416-322-5075 The post POET Technologies Secures Financing of US$400 Million in a Registered Direct Offering of Common Shares and Warrant appeared first on Montreal Gazette.

AUSTIN, Texas, May 15, 2026 (GLOBE NEWSWIRE) — via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled “The Next Generation of the GLP-1 Revolution Is Already Underway,” featuring SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF). To hear the NetworkNewsAudio version, visit:  To read the original editorial, visit:  SureNano Science is advancing GEP-44 as a patented, next-generation metabolic therapy intended to improve upon limitations associated with first-generation GLP-1 drugs, positioning this emerging microcap as a minnow among giants quickly transitioning through the FDA pathway. Unlike conventional GLP-1 agonists that primarily target a single receptor pathway, GEP-44 functions as a triple agonist targeting GLP-1 and peptide YY receptors Y1 and Y2. This integrated mechanism is designed to simultaneously regulate glucose metabolism, suppress appetite and improve tolerability within a single molecule. The compound was developed at Syracuse University and has demonstrated encouraging preclinical results. According to the company, GEP-44 produced meaningful reductions in food intake and body weight while also improving glycemic control in preclinical studies. Importantly, the compound reportedly avoided the nausea and gastrointestinal side effects commonly associated with many first-generation GLP-1 therapies, a factor that could become increasingly important as patient adoption expands. About SureNano Science Ltd. SureNano Science Ltd. (CSE: SURE) is a Canadian life sciences company focused on acquiring, developing and advancing innovative pharmaceutical and biotechnology assets with the potential to address large and growing global health markets. SureNano Science Ltd. has acquired GlucaPharm Inc., a next-generation GLP-1 pharmaceutical company developing GEP44, a patented peptide targeting obesity and metabolic disorders with improved tolerability and potential noninjectable delivery. The initial business of SureNano Science Ltd. is the sale and distribution of the SureNano(TM) surfactant, which is a ready-to-mix food grade compound that provides the base for high performance nanoemulsions to create incredibly homogeneous and stable products while maximizing bioavailability, clarity, and taste. The Company has an exclusive license to distribute the SureNano(TM) surfactant within Canada; Oklahoma, USA; and Colorado, USA. SureNano Science Ltd. is now developing into a pharmaceutical focused company through the advancement of a patented therapeutic candidate designed to address obesity and metabolic disease. For more information, visit the company’s website at www.SureNano.com. NOTE TO INVESTORS: The latest news and updates relating to SURNF are available in the company’s newsroom at     About NetworkNewsAudio NetworkNewsAudio, a service of NetworkNewsWire (NNW), a multifaceted financial news and publishing company powered by IBN (“InvestorBrandNetwork”), allows you to sit back and listen to market updates, interviews and company press releases. NetworkNewsAudio keeps you informed on publicly traded companies we’re watching. The audio clips provide snapshots of position, opportunity and momentum. NetworkNewsAudio is a Brand Awareness Distribution Solution from NetworkNewsWire. For more information, visit: www.NetworkNewsAudio.com NetworkNewsWire (NNW) is a comprehensive provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW has the unparalleled ability to reach a wide audience of investors, consumers, journalists and the general public. With an ever-growing distribution network of more than 5,000 key syndication outlets across the nation, NNW cuts through the overload of information in today’s markets bringing its clients unparalleled visibility, recognition and brand awareness. NetworkNewsWire is where news, content and information converge. Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:  Forward-Looking Statements This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements. Corporate CommunicationsIBNAustin, Texaswww.InvestorBrandNetwork.com512.354.7000 OfficeEditor@InvestorBrandNetwork.com The post NetworkNews Audio Announces Audio Press Release (APR) Discussing Overcoming Limitations on First-Generation GLP-1 Drug Therapies appeared first on Montreal Gazette.

The military reprimanded soldiers after they raised concerns about an order to monitor Canadians' online activity during the COVID-19 pandemic, CBC News has learned.

A Liberal government bill that proposes giving police and spies easier access to information during investigations has fallen into the crosshairs of U.S. tech giants and two American congressional committees, threatening to become the latest irritant in the Canada-U.S. relationship.

Members of Canada's largest white nationalist group, Second Sons Canada, have met to train and network with a number of "active clubs" from the United States, and also met with active club movement founder Robert Rundo, who is currently on supervised release for violent offences.

U.S. President Donald Trump departed China on Friday touting business deals that gave markets little to cheer, while Beijing warned Washington about mishandling Taiwan and said its war with Iran should never have started.

After Game 5 of their series against the Buffalo Sabres, the Montreal Canadiens are only one win away from the final four. Brian Wilde has more.

Artemis II crew gets hero's welcome at Canadian Space Agency headquarters in Quebec after historic journey to the far side of the moon.

Abortion pills are the most common method of terminating pregnancies in the US.

An industry body survey found hotels in World Cup host cities see the tournament as a "non-event".

Second BRICS meeting in a row collapses without joint position because of disagreements over the war on Iran.

Beckham and his wife Victoria's collective wealth reached the milestone this year, according to Sunday Times Rich List.